Dignitana receives FDA clearance for DigniCap Delta scalp cooling system
(World News Science)

Lund, Sweden 27 June 2019 Dignitana receives FDA clearance for DigniCap Delta scalp cooling system Clinically superior next generation device reduces hair loss for cancer patients Dignitana AB, world leader in medical scalp cooling technology, announced today that the United States Food and Drug Administration has cleared DigniCap Delta® for use by U.S. health care providers. The new device is the fourth generation of The DigniCap® Scalp Cooling System and is indicated to prevent chemotherapy-induced hair loss in patients with solid tumors. European installations of DigniCap Delta began last month after the device received CE Marking in March 2019. "DigniCap Delta changes everything...